Arcutis Biotherapeutics, Inc. Common Stock ARQT
$24.25
+1.53%
at last close
Financials (TTM)
- Revenue
- $463.98 million
- Net Income
- $28.52 million
- Net Margin
- 6.15%
- Return on Equity
- 12.93%
- Debt-to-Equity
- 0.49
- P/E Ratio
- 115.48
- Price / Book
- 13.61
- Price / Sales
- 6.47
Over the trailing twelve months, Arcutis Biotherapeutics, Inc. Common Stock generated revenue of $463.98 million and net income of $28.52 million, a net margin of 6.15%.
At the last closing price of $24.25, ARQT trades at 115.48 times trailing earnings and 6.47 times sales, with a market capitalization of $3.00 billion.
Key Stats
- Last Close
- $24.25
- Market Cap
- $3.00 billion
- 52-Week Range
- $14.03 – $31.77
- Average Volume
- 1.85 million shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.